Ovid Therapeutics Inc. (OVID) Earnings Per Share (EPS)
Ovid Therapeutics Inc. (OVID) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | -$1.39 |
| 2021-12-31 | $1.78 |
| 2022-12-31 | -$0.77 |
| 2023-12-31 | -$0.74 |
| 2024-12-31 | -$0.37 |
| 2025-12-31 | -$0.23 |
How OVID compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| NEOG | Neogen Corporation | -$0.04 |
| LXRX | Lexicon Pharmaceuticals Inc. | -$0.14 |
| DYAI | Dyadic International Inc. | -$0.23 |
| MNOV | MediciNova Inc. | -$0.24 |
| TRVI | Trevi Therapeutics Inc. | -$0.32 |
These are five companies in the same sector as OVID with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Ovid Therapeutics Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("OVID")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | OVID | $2.80 | +0.72% | 1.07M |
| 3 | ||||
| 4 | ||||
| 5 |